Tag: Johnson & Johnson

May 14, 2019

5 Top Pharmaceutical ETFs

A wide range of investors may want to consider pharmaceutical ETFs as a way to stay informed about and invest...
April 18, 2019

Pharma Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
March 6, 2019

FDA Approves Johnson & Johnson’s Nasal Spray Antidepressant

Spravato, which is administered via a nasal spray, is the first FDA-approved antidepressant in over 30 years.
February 26, 2019

Senate Finance Committee Blasts Pharma CEOs on Drug Prices

This was the largest panel of pharmaceutical executives "in decades" to appear before a congressional committee.
December 26, 2018

5 Top Genetics News Stories of 2018

What caught the attention of readers in the genetics market this year? We've compiled a list of our top genetics...
October 24, 2018

Zymeworks Makes First Dermatology Licensing Deal

This is the first joint antibody discovery and development collaboration for Zymeworks and marks the first dermatology-specific partnership for the...
October 16, 2018

Pharmaceutical Update: Q3 2018 in Review

With Q3 behind us and Q4 already in full swing, the Investing News Network is providing a look at some...